During the tumor progression, TGFβ is responsible for changing intratumoral neutrophils phenotype, from N1 (pro-inflammatory) to N2 (anti-inflammatory), allowing the tumor to grow without any immune interference26. The gene discussed is TGFB1; the disease is neoplasm.